"The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of selexipag (Uptravi, Actelion Registration Ltd) for the treatment of adults with pulmonary arterial hypertension (PAH)./"...
The following adverse reactions have been observed, but there are insufficient data to support an estimate of their frequency.
*These so-called "side effects" are actually evidence of adrenergic blockade and vary according to the degree of blockade.
Read the Dibenzyline (phenoxybenzamine) Side Effects Center for a complete guide to possible side effects
2-Dibenzyline (phenoxybenzamine hydrochloride) may interact with compounds that stimulate both alpha- and beta-adrenergic receptors (i.e., epinephrine) to produce an exaggerated hypotensive response and tachycardia. (See WARNING.)
2. Martin, E.W.: Drug Interactions Index 1978/1979, Philadelphia, J.B. Lippincott Co., 1978, pp. 209-210.
Read the Dibenzyline Drug Interactions Center for a complete guide to possible interactions
Last reviewed on RxList: 5/14/2008
Additional Dibenzyline Information
Dibenzyline - User Reviews
Dibenzyline User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on handling your hypertension.